Understanding Breast Cancer Risk through Research
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
- Age
- 18 – 100
- Sex
- Female
- Study type
- Observational
- Participants needed
- 4,500 (estimated)
- Sponsor
- Mayo Clinic · Other
This trial is looking for women aged 18 to 100 who had a benign breast biopsy at the Mayo Clinic between 2002 and 2022. By participating, you will help researchers learn how benign breast conditions can relate to breast cancer.
You may be able to join if
- I am a female patient aged 18 to 100.
- I had a benign breast biopsy at Mayo Clinic between 2002 and 2022.
You may not be able to join if
- I am a male patient.
- I have been diagnosed with breast cancer before.
- I was diagnosed with breast cancer within the last six months.
- I have declined to allow my information to be used in research.
- I have had a bilateral prophylactic mastectomy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Loading trial locations…